Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats

被引:14
作者
Chesler, Kyle [1 ,2 ,3 ]
Motz, Cara [1 ,2 ,3 ]
Vo, Harrison [1 ]
Douglass, Amber [1 ]
Allen, Rachael S. [1 ,2 ,3 ]
Feola, Andrew J. [1 ,2 ,3 ]
Pardue, Machelle T. [1 ,2 ,3 ]
机构
[1] Atlanta VA Healthcare Syst, Atlanta, GA USA
[2] Georgia Inst Technol, Biomed Engn, Atlanta, GA 30332 USA
[3] Emory Univ, Atlanta, GA 30322 USA
来源
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY | 2021年 / 10卷 / 04期
关键词
diabetes; retina; dopamine; retinopathy; neuroprotection; VASCULAR-PERMEABILITY; PARKINSONS-DISEASE; VISUAL DYSFUNCTION; MODEL; LEVODOPA; DEFICITS; ELECTRORETINOGRAM; THERAPY; DELAYS; STRIATUM;
D O I
10.1167/tvst.10.4.8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: L-DOPA treatment initiated at the start of hyperglycemia preserves retinal and visual function in diabetic rats. Here, we investigated a more clinically relevant treatment strategy in which retinal and visual dysfunction designated the beginning of the therapeutic window for L-DOPA treatment. Methods: Spatial frequency thresholds using optomotor response and oscillatory potential (OP) delays using electroretinograms were compared at baseline, 3, 6, and 10 weeks after streptozotocin (STZ) between diabetic and control rats. L-DOPA/carbidopa treatment (DOPA) or vehicle was delivered orally 5 days per week beginning at 3 weeks after STZ, when significant retinal and visual deficits were measured. At 10 weeks after STZ, retinas were collected to measure L-DOPA, dopamine, and 3,4-dihydroxyphenylacetic acid (DOPAC) levels using high-performance liquid chromatography. Results: Spatial frequency thresholds decreased at 6 weeks in diabetic vehicle rats (28%), whereas diabetic DOPA rats had stable thresholds (<1%) that maintained to 10 weeks, creating significantly higher thresholds compared with diabetic vehicle rats (P < 0.0001). OP2 implicit times in response to dim, rod-driven stimuli were decreased in diabetic compared with control rats (3 weeks, P < 0.0001; 10 weeks, P < 0.01). With L-DOPA treatment, OP2 implicit times recovered in diabetic rats to be indistinguishable from control rats by 10 weeks after STZ. Rats treated with L-DOPA showed significantly increased retinal L-DOPA (P < 0.001) and dopamine levels (P < 0.05). Conclusions: L-DOPA treatment started after the detection of retinal and visual dysfunction showed protective effects in diabetic rats. Translational Relevance: Early retinal functional deficits induced by diabetes can be used to identify an earlier therapeutic window for L-DOPA treatment which protects from further vision loss and restores retinal function.
引用
收藏
页数:12
相关论文
共 63 条
[1]   EFFECTS OF L-DOPA ON EXTRACELLULAR DOPAMINE IN STRIATUM OF NORMAL AND 6-HYDROXYDOPAMINE-TREATED RATS [J].
ABERCROMBIE, ED ;
BONATZ, AE ;
ZIGMOND, MJ .
BRAIN RESEARCH, 1990, 525 (01) :36-44
[2]   Validity, Usefulness and Cost of RETeval System for Diabetic Retinopathy Screening [J].
Al-Otaibi, Humoud ;
Al-Otaibi, Mohammed D. ;
Khandekar, Rajiv ;
Souru, Ches ;
Al-Abdullah, Abdulelah A. ;
Al-Dhibi, Hassan ;
Stone, Donald U. ;
Kozak, Igor .
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2017, 6 (03)
[3]  
Allen CL, 2016, INVEST OPHTH VIS SCI, V57
[4]   Retinal Deficits Precede Cognitive and Motor Deficits in a Rat Model of Type II Diabetes [J].
Allen, Rachael S. ;
Feola, Andrew ;
Motz, Cara T. ;
Ottensmeyer, Amy L. ;
Chesler, Kyle C. ;
Dunn, Ryan ;
Thule, Peter M. ;
Pardue, Machelle T. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (01) :123-133
[5]  
Aung M, 2013, INVEST OPHTH VIS SCI, V54
[6]   Early Visual Deficits in Streptozotocin-Induced Diabetic Long Evans Rats [J].
Aung, Moe H. ;
Kim, Moon K. ;
Olson, Darin E. ;
Thule, Peter M. ;
Pardue, Machelle T. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (02) :1370-1377
[7]   The Significance of Vascular and Neural Apoptosis to the Pathology of Diabetic Retinopathy [J].
Barber, Alistair J. ;
Gardner, Thomas W. ;
Abcouwer, Steven F. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (02) :1156-1163
[8]   The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor [J].
Basu, S ;
Nagy, JA ;
Pal, S ;
Vasile, E ;
Eckelhoefer, IA ;
Bliss, VS ;
Manseau, EJ ;
Dasgupta, PS ;
Dvorak, HF ;
Mukhopadhyay, D .
NATURE MEDICINE, 2001, 7 (05) :569-574
[9]   A multifocal electroretinogram model predicting the development of diabetic retinopathy [J].
Bearse, Marcus A., Jr. ;
Adams, Anthony J. ;
Han, Ying ;
Schneck, Marilyn E. ;
Ng, Jason ;
Bronson-Castain, Kevin ;
Barez, Shirin .
PROGRESS IN RETINAL AND EYE RESEARCH, 2006, 25 (05) :425-448
[10]   Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence [J].
Boyle, James P. ;
Thompson, Theodore J. ;
Gregg, Edward W. ;
Barker, Lawrence E. ;
Williamson, David F. .
POPULATION HEALTH METRICS, 2010, 8